Jay Luly - President and CEO, Enanta Pharmaceuticals Inc

As of September 17, 2021


Jay Luly Net Worth

  • Net worth is estimated to be at least $45.79M
  • Owns at least 676,972 units of Enanta Pharmaceuticals Inc stock
  • Sold an estimated value of $7.89M in the last 8 years at Enanta Pharmaceuticals Inc

Jay Luly Trading

  • Largest sale of shares was 35,000 units , worth over $4.38M on July 9, 2018
  • In total has made about 26 transactions over 8 years
  • Usually trades in November, with the busiest year in 2016
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Jay Luly Mailing Address

  • Mailing address is C/o Enanta Pharmaceuticals, Inc. 500 Arsenal Street Watertown MA 02472 MA

Enanta Pharmaceuticals Inc Insider Trading

  • The most recent transaction was 4,516 units sold on September 17, 2021 by Jay Luly worth over $266.7K
  • In the last 8 years, insiders at Enanta Pharmaceuticals Inc sold an estimated value of $83.94M and bought an estimated value of $10.38M
  • The most active traders are Paul Mellett, Treasurer and CFO,  Jay Luly, President and CEO,  and Nathaniel S. Gardiner As Attorney-In-Fact, Sr. VP & CSO
  • Insider trading is most common in February, with the busiest year in 2014

ENANTA PHARMACEUTICALS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1